Can a common pill shield ICU survivors from future heart attacks?
NCT ID NCT05272878
Summary
This study is testing whether a blood pressure medication (an ARB called irbesartan) can help prevent future heart problems in people who survived a stay in the intensive care unit (ICU) and had acute kidney injury. About 508 participants will be randomly assigned to take either the real medication or a placebo pill for one year to see if it reduces their risk of heart failure, stroke, or heart attacks. The goal is to see if this treatment can improve long-term health for this high-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Lariboisière
Paris, 75010, France
Conditions
Explore the condition pages connected to this study.